Refractory Dissecting Cellulitis of the Scalp Treated With Adalimumab

October 2008 | Volume 7 | Issue 10 | Case Reports | 981 | Copyright © October 2008

Smita V. Sukhatme BS, Yolanda M. Lenzy MD MPH, Alice B. Gottlieb MD PhD

Abstract
Dissecting cellulitis of the scalp (DCS) is a suppurative, neutrophillic dermatosis. Therapies typically provide short-term improvement and include antibiotics, prednisone, and isotretinoin, as well as radiation, surgical excision, and laser ablation. The authors report the use of the tumor necrosis factor (TNF) blocker, adalimumab, to successfully treat a 39-year-old male with a long-standing history of DCS.